BAC2021 banner thin Veertly(3).png

Thank you for joining us!

The ways in which we treat diseases are becoming more and more innovative, with the biotech industry demonstrating its full potential in the development of new ways to treat patients.

Our industry is constantly inventing, validating, and developing new drug modalities such as antibody-drug conjugates, RNA therapeutics, targeted degradation, gene editing, oligonucleotides and various combinations of these and other tools to address pathophysiological conditions.

Collaboration among industry, academia, regulatory, clinician and patient communities, as well as ad hoc funding and investment frameworks are essential to bring these solutions to the patients.

This year Annual Conference presented some of these biotechnology-driven new therapeutical approaches and partnership models for successful drug development.

On-demand content

Morning Session

Afternoon Session

Impressions

Source: BioRN

Since 2009, each year the BioRN Annual Conference has been a valuable source of top information, lively discussions and networking opportunities with international experts from different fields of the life sciences.

Sponsors

boehringer-ingelheim-logo-e1522070562631
2000px-Hoffmann-La_Roche_logo.svg.png

Conference

Supporter

AbbVie-Logo-EPS-vector-image (2).png
Merck_LOGO_highres_RGB_VM.jpg
cytiva_logo_hz_color_pos_rgb.jpg
GSK_LOS_3D_RGB.png

Workshop Partner

Cytel_Logo_Cobalt_blue_200px (1).png

Key Public Partner

TP-Logo.png